A Phase l/ll Study of Quinidine, a Potential Multidrug Resistance-Reversing Agent, in Combination with Pirarubicin in Patients with Advanced Refractory Breast Cancer
1993 ◽
Vol 16
(6)
◽
pp. 450-453
◽
2021 ◽
Vol 62
◽
pp. 102405
2014 ◽
Vol 35
(23)
◽
pp. 6047-6059
◽
2020 ◽
Vol 23
◽
pp. 102095
2008 ◽
Vol 32
(3)
◽
pp. S28-S28
◽
2003 ◽
Vol 51
(5)
◽
pp. 407-414
◽
Keyword(s):
Keyword(s):
Keyword(s):